— Item 23 of 40 = y Mark <J e L i @ a 5

— " . L ~
Question Id: 22785 Praras Next FullScreen Tutorial__—_Lab Values Notes

Researchers are investigating the use of immune checkpoint inhibitors for the treatment of
advanced colorectal cancer. They find that this therapy is more effective in patients with DNA
mismatch-repair deficiency compared to patients with an intact mismatch-repair mechanism.
Which of the following most likely explains the improved efficacy of the drug in the first group

of patients?

© A. Higher burden of tumor neoantigens
© B. Increased MHC class | expression in tumor cells
©) C. Increased number of regulatory T cells

©) D. Increased synthesis of metalloproteinases

©) E. Lower frequency of DNA mutations

Block Time Elapse

Tutor

Calculator

e @A 8

Reverse Color _Text Zoom Settings

Activate Windows

Feedback id ~~ End Block
